PLX - Protalix Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PLX is currently covered by 1 analysts with an average price target of $12. This is a potential upside of $9.41 (363.32%) from yesterday's end of day stock price of $2.59.

Protalix Biotherapeutics's activity chart (see below) currently has 15 price targets and 15 ratings on display. The stock rating distribution of PLX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.22% with an average time for these price targets to be met of 52 days.

Highest price target for PLX is $12, Lowest price target is $12, average price target is $12.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2026. First documented stock forecast 09-Nov-2012.

Best performing analysts who are covering PLX - Protalix Biotherapeutics:

Peter Welford Raghuram Selvaraju

Currently out of the existing stock ratings of PLX, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Apr-2016

$12

$9.41 (363.32%)

1 months 23 days ago
(09-Sep-2026)

0/8 (0%)

$9.33 (349.44%)

Buy Since 23-Apr-2015

$21

$18.41 (710.81%)

$17.5

9 years 13 days ago
(19-Oct-2017)

1/5 (20%)

$13.19 (168.89%)

14

Show more analysts

Please expand the browser size to see the chart

What is PLX (Protalix Biotherapeutics) average time for price targets to be met?

On average it took 52 days for the stock forecasts to be reached, with an average price target met ratio of 12.22%.

Which analyst most recently updated their price target on PLX (Protalix Biotherapeutics)?

Raghuram Selvaraju

Which analyst has the most public recommendations on PLX (Protalix Biotherapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 12 price targets and 12 ratings on PLX

Which analyst is the currently most bullish on PLX (Protalix Biotherapeutics)?

Peter Welford with the highest potential upside of $18.41

Which analyst is the currently most reserved on PLX (Protalix Biotherapeutics)?

Raghuram Selvaraju with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?